FERRANDIS ERIC

No ORCID on file · 28 papers in corpus · active 2002-2005
2005
Benzimidazole derivatives and their use as GnRH antagonists

Benzimidazole derivatives of general formula (I) are disclosed. These compounds have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. Compounds of formula (I) are useful in the preparation of a medicament for: the treatment, in …

2005
Benzimidazole derivatives and their use as GnRH antagonists

Benzimidazole derivatives of general formula (I) are disclosed. These compounds have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. Compounds of formula (I) are useful in the preparation of a medicament for: the treatment, in …

2005
Benzimidazole derivatives and their use as GnRH antagonists

Benzimidazole derivatives of general formula (I) are disclosed. These compounds have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. Compounds of formula (I) are useful in the preparation of a medicament for: the treatment, in …

2005
Benzimidazole derivatives and their use as GnRH antagonists

Benzimidazole derivatives of general formula (I) are disclosed. These compounds have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. Compounds of formula (I) are useful in the preparation of a medicament for: the treatment, in …

2005
Benzimidazole derivatives and their use as GnRH antagonists

Benzimidazole derivatives of general formula (I) are disclosed. These compounds have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. Compounds of formula (I) are useful in the preparation of a medicament for: the treatment, in …

2005
Benzimidazole derivatives and their use as GnRH antagonists

Benzimidazole derivatives of general formula (I) are disclosed. These compounds have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. Compounds of formula (I) are useful in the preparation of a medicament for: the treatment, in …

2005
Benzimidazole derivatives and their use as GnRH antagonists

Benzimidazole derivatives of general formula (I) are disclosed. These compounds have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. Compounds of formula (I) are useful in the preparation of a medicament for: the treatment, in …

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2002
New isolated human gonadotropin-releasing hormone receptors and nucleic acids, useful for treating disorders associated with gonadal steroids, e.g. endometriosis

Isolated gonadotropin-releasing hormone receptors (GnRH-R2): (i) comprising a 354 amino acid (aa) sequence (A1) or 379 aa sequence (A2); or (ii) encoded by a sequence that hybridizes with a 1174 bp sequence (N1) or 1249 bp sequence (N2).…

2002
New isolated human gonadotropin-releasing hormone receptors and nucleic acids, useful for treating disorders associated with gonadal steroids, e.g. endometriosis

Isolated gonadotropin-releasing hormone receptors (GnRH-R2): (i) comprising a 354 amino acid (aa) sequence (A1) or 379 aa sequence (A2); or (ii) encoded by a sequence that hybridizes with a 1174 bp sequence (N1) or 1249 bp sequence (N2).…

2002
New isolated human gonadotropin-releasing hormone receptors and nucleic acids, useful for treating disorders associated with gonadal steroids, e.g. endometriosis

Isolated gonadotropin-releasing hormone receptors (GnRH-R2): (i) comprising a 354 amino acid (aa) sequence (A1) or 379 aa sequence (A2); or (ii) encoded by a sequence that hybridizes with a 1174 bp sequence (N1) or 1249 bp sequence (N2).…

2002
New isolated human gonadotropin-releasing hormone receptors and nucleic acids, useful for treating disorders associated with gonadal steroids, e.g. endometriosis

Isolated gonadotropin-releasing hormone receptors (GnRH-R2): (i) comprising a 354 amino acid (aa) sequence (A1) or 379 aa sequence (A2); or (ii) encoded by a sequence that hybridizes with a 1174 bp sequence (N1) or 1249 bp sequence (N2).…

2002
New isolated human gonadotropin-releasing hormone receptors and nucleic acids, useful for treating disorders associated with gonadal steroids, e.g. endometriosis

Isolated gonadotropin-releasing hormone receptors (GnRH-R2): (i) comprising a 354 amino acid (aa) sequence (A1) or 379 aa sequence (A2); or (ii) encoded by a sequence that hybridizes with a 1174 bp sequence (N1) or 1249 bp sequence (N2).…

2002
New isolated human gonadotropin-releasing hormone receptors and nucleic acids, useful for treating disorders associated with gonadal steroids, e.g. endometriosis

Isolated gonadotropin-releasing hormone receptors (GnRH-R2): (i) comprising a 354 amino acid (aa) sequence (A1) or 379 aa sequence (A2); or (ii) encoded by a sequence that hybridizes with a 1174 bp sequence (N1) or 1249 bp sequence (N2).…

2002
New isolated human gonadotropin-releasing hormone receptors and nucleic acids, useful for treating disorders associated with gonadal steroids, e.g. endometriosis

Isolated gonadotropin-releasing hormone receptors (GnRH-R2): (i) comprising a 354 amino acid (aa) sequence (A1) or 379 aa sequence (A2); or (ii) encoded by a sequence that hybridizes with a 1174 bp sequence (N1) or 1249 bp sequence (N2).…

2002
New isolated human gonadotropin-releasing hormone receptors and nucleic acids, useful for treating disorders associated with gonadal steroids, e.g. endometriosis

Isolated gonadotropin-releasing hormone receptors (GnRH-R2): (i) comprising a 354 amino acid (aa) sequence (A1) or 379 aa sequence (A2); or (ii) encoded by a sequence that hybridizes with a 1174 bp sequence (N1) or 1249 bp sequence (N2).…

2002
New isolated human gonadotropin-releasing hormone receptors and nucleic acids, useful for treating disorders associated with gonadal steroids, e.g. endometriosis

Isolated gonadotropin-releasing hormone receptors (GnRH-R2): (i) comprising a 354 amino acid (aa) sequence (A1) or 379 aa sequence (A2); or (ii) encoded by a sequence that hybridizes with a 1174 bp sequence (N1) or 1249 bp sequence (N2).…

2002
New isolated human gonadotropin-releasing hormone receptors and nucleic acids, useful for treating disorders associated with gonadal steroids, e.g. endometriosis

Isolated gonadotropin-releasing hormone receptors (GnRH-R2): (i) comprising a 354 amino acid (aa) sequence (A1) or 379 aa sequence (A2); or (ii) encoded by a sequence that hybridizes with a 1174 bp sequence (N1) or 1249 bp sequence (N2).…

2002
New isolated human gonadotropin-releasing hormone receptors and nucleic acids, useful for treating disorders associated with gonadal steroids, e.g. endometriosis

Isolated gonadotropin-releasing hormone receptors (GnRH-R2): (i) comprising a 354 amino acid (aa) sequence (A1) or 379 aa sequence (A2); or (ii) encoded by a sequence that hybridizes with a 1174 bp sequence (N1) or 1249 bp sequence (N2).…